Human ex vivo models of interstitial lung disease

Symposium
Chairs: R. Gosens (Groningen, Netherlands), M. Proesmans (Leuven, Belgium)
Aims: To present models of early events of idiopathic pulmonary fibrosis (IPF) ex vivo and the use of these models in evaluating pathogenesis and treatment; and to evaluate the potential use of lung organoids for drug screening.

3D tissue culture to study the mechanisms of lung repair in IPF M. Konigshoff (Denver, United States of America)
Using induced pluripotent stem cells to study the type II pneumocyte K. Hurley (Dublin 3, Ireland)
Lung-on-a -chip: state of the art N. Roldan (Bern, Switzerland)
The role of cell lines in modelling the type II pneumocyte in interstitial lung disease J. Dickens (Cambridge (Cambridgeshire), United Kingdom)